Vivani Medical, Inc. Common Stock (DE) (VANI) News
Latest headlines that mention VANI, newest first · each headline opens the original publisher
- Last price
- $1.13
- Day change
- +1.80%
- Next earnings
- 2026-11-12
VANI headlines
latest coverageNot much coverage yet. VANI has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
VANI news alerts
Get an alert by email or push when a new headline mentions VANI.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.